HIF1A and neoplasm: Sarcoma is traditionally considered an immunologically quiet tumor with low tumor mutational burden (1.06 mutations/Mb) and immunosuppressive TME (high levels of hypoxia-inducible factor 1 α (HIF1α), macrophages, neutrophils, and decreased T-cell levels) (6).